AKT1 and breast carcinoma: Besides, SSA can downregulate the expression of p-STAT3 and p-AKT in breast cancer cells, reduce cellular lactate levels, ATP content, and glucose uptake, and attenuate glycolysis in breast cancer cells (Zhang et al., 2023).